Compare Darmi Bersaudara Tbk. (KAYU) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Darmi Bersaudara Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Darmi Bersaudara Tbk. trades at Rp18 (market cap 11.97B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Organon Pharma Indonesia Tbk. is far larger — about 8.7× Darmi Bersaudara Tbk.'s market cap. Which is the better fit depends on your goals.
| KAYU | SCPI | |
|---|---|---|
Market Cap | 11.97B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Darmi Bersaudara Tbk.
PT Darmi Bersaudara Tbk (the Entity) was established based on the Notarial Deed of Ellen, S.H., Notary in Surabaya, No. 3, dated June 3, 2010, which was approved by the Ministry of Law and Human Rights of the Republic of Indonesia based on letter No. AHU-37538.AH.01.01.Tahun 2010, dated July 29, 2010.
Read more on KAYU →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
